PAQ
featured

We are open as normal during COVID-19 pandemic. Order online, same day shipping out.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 574232

CAS#: 943902-10-1

Description: PAQ is a neuroprotective agent. It protects dopaminergic neurons from cell death without inhibiting glial cell proliferation. PAQ prevents loss of dopaminergic neurons in the substantia nigra in a mouse model of Parkinson’s disease induced by MPTP.


Price and Availability

Size Price Shipping out time Quantity
1mg USD 215 2 Weeks
5mg USD 445 2 Weeks
10mg USD 725 2 Weeks
25mg USD 1400 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-07-10. Prices are subject to change without notice.

PAQ, purity > 95%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 574232
Name: PAQ
CAS#: 943902-10-1
Chemical Formula: C14H11N3
Exact Mass: 221.0953
Molecular Weight: 221.26
Elemental Analysis: C, 76.00; H, 5.01; N, 18.99


Synonym: PAQ

IUPAC/Chemical Name: 3-phenyl-6-quinoxalinamine

InChi Key: BTTJRYBJJULOGN-UHFFFAOYSA-N

InChi Code: InChI=1S/C14H11N3/c15-11-6-7-12-13(8-11)17-14(9-16-12)10-4-2-1-3-5-10/h1-9H,15H2

SMILES Code: NC1=CC=C(N=CC(C2=CC=CC=C2)=N3)C3=C1


Technical Data

Appearance:
Solid powder

Purity:
>95% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1. Le Douaron, G., Ferrié, L., Sepulveda-Diaz, J.E., et al. New 6-aminoquinoxaline derivatives with neuroprotective effect on dopaminergic neurons in cellular and animal parkinson disease models. J. Med. Chem. 59(13), 6169-6186 (2016).